Who is sponsoring NCT03568695?

NCT03568695 is sponsored by Centre Hospitalier Régional d'Orléans.

What drugs are being tested in NCT03568695?

Interventions in NCT03568695: Two samples on each of the three sites (pharynx, rectum, urine).

What condition does NCT03568695 study?

NCT03568695 studies Chlamydia Trachomatis Infection, Neisseria Gonorrheae Infection, Mycoplasma Genitalium Infection, Sensitivity, Polymerase Chain Reaction.

Is NCT03568695 still recruiting?

NCT03568695 is currently completed. Last updated 1 September 2020.

Last reviewed 2020-09-01 · How we verify

NCT03568695: ISTPOOL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Detection of Chlamydia Trachomatis, Neisseria Gonorrhoeae and Mycoplasma Genitalium by Real-time Multiplex Polymerase Chain Reaction (PCR) After Pooling Pharyngeal, Anorectal and Urinary Samples

Completed NA Last updated 1 September 2020

What this trial tests

NA trial testing Two samples on each of the three sites (pharynx, rectum, urine) in Chlamydia Trachomatis Infection in 166 participants. Completed in 16 June 2020.

Timeline

29 June 2018

Primary endpoint
16 June 2020

16 June 2020

Quick facts

Lead sponsor	Centre Hospitalier Régional d'Orléans
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	166
Start date	29 June 2018
Primary completion	16 June 2020
Estimated completion	16 June 2020
Sites	5 locations across France

Drugs / interventions tested

Two samples on each of the three sites (pharynx, rectum, urine)

Conditions studied

Chlamydia Trachomatis Infection — all drugs for Chlamydia Trachomatis Infection →
Neisseria Gonorrheae Infection — all drugs for Neisseria Gonorrheae Infection →
Mycoplasma Genitalium Infection — all drugs for Mycoplasma Genitalium Infection →
Sensitivity — all drugs for Sensitivity →

Sponsor

Centre Hospitalier Régional d'Orléans

Who can join

18 and older, male only, with Chlamydia Trachomatis Infection or Neisseria Gonorrheae Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare the sensitivity of detecting Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium by real-time multiplex PCR in a pooled analysis (i.e. gathering pharyngeal, anorectal and urinary samples) versus the standard of care (where a real-time multiplex PCR is made in each of the three samples).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pooling Rectal, Pharyngeal, and Urine Samples to Detect Neisseria gonorrhoeae, Chlamydia trachomatis, and Mycoplasma genitalium Using Multiplex Polymerase Chain Reaction Is as Effective as Single-Site Testing for Men Who Have Sex With Men.
Prazuck T, Lanotte P, Le Moal G, Hocqueloux L, et al · · 2022 · cited 4× · PMID 36324326 · DOI 10.1093/ofid/ofac496

Verify or expand the search:

Other recruiting trials for Chlamydia Trachomatis Infection

Currently open trials in the same condition.

NCT05666778 — Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs · Phase 2 · active not recruiting

Other Centre Hospitalier Régional d'Orléans trials

Trials by the same sponsor.

NCT07522307 — Psychological Impact of an 80-km Ultra-Endurance Race · recruiting
NCT07522333 — Psychological Impact of an 120-km Ultra-Endurance Race · recruiting
NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method · NA · recruiting
NCT07203807 — Study of the Optimal Number of Repetitions to Investigate the Cerebral Activity by fNIRS During a Voluntary Movement and · completed
NCT07305701 — Cohort Study on Medical Students' Mental Health · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03568695 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Régional d'Orléans
Last refreshed: 1 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03568695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing